August 31, 2021 The perfect Combination
We have further strengthened our strategic collaboration with Vetter to offer complementary expertise to our mutual clients. By optimally aligning our processes, we can reduce lag times, coordination efforts and development risks associated with working with multiple CDMOs.
While we specialize in drug substance manufacturing, including bioprocess development as well as clinical and commercial production, our strategic partner Vetter has long-standing experience in drug product manufacturing, including process design, as well as clinical and commercial fill and finish.
Please find insights into our collaboration with Vetter, in the latest issue of the transkript magazine1 (German article): Download
1 |transkript, Ausgabe 3-2021, © BIOCOM AG
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication